|
000
| 02807nam 2200517zi 4500 |
|---|
| 001 | 9.924904 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20231103112204 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 230710t20232023onca ob f000 0 eng d |
|---|
| 020 | |a9780660494302 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-444/2023E-PDF |
|---|
| 245 | 00|aUse of public health measures (PHMs), advice and risk assessment survey : |breport / |cprepared for the Public Health Agency of Canada. |
|---|
| 246 | 3 |aUse of public health measures (PHMs), advice and risk assessment survey : |bfinal report |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2023. |
|---|
| 264 | 4|c©2023 |
|---|
| 300 | |a1 online resource (83 pages) : |bcolour illustration + |eexecutive summary (10 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Enquête sur l'utilisation des conseils sur les mesures de santé publique (MSP) et l'évaluation des risques : rapport. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Supplier name: Abacus Data." |
|---|
| 500 | |a"Contract number: CW2245692 - 6D034-225051." |
|---|
| 500 | |a"Registration number: POR 063-22." |
|---|
| 500 | |a"March 2023"--Page 2. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aCOVID-19 (Disease)|zCanada|xSafety measures|xPublic opinion. |
|---|
| 650 | 0|aRespiratory syncytial virus|zCanada|xSafety measures|xPublic opinion. |
|---|
| 650 | 0|aInfluenza|zCanada|xSafety measures|xPublic opinion. |
|---|
| 650 | 0|aRisk perception|zCanada. |
|---|
| 650 | 0|aPublic health|zCanada|xPublic opinion. |
|---|
| 650 | 0|aPublic opinion|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 710 | 2 |aAbacus Data, |econsultant. |
|---|
| 775 | 08|tEnquête sur l'utilisation des conseils sur les mesures de santé publique (MSP) et l'évaluation des risques : |w(CaOODSP)9.924905 |
|---|
| 856 | 40|qPDF|s1.70 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/H14-444-2023-eng.pdf|z(report) |
|---|
| 856 | 40|qPDF|s436 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/H14-444-2023-1-eng.pdf|z(executive summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/063-22-e/report.html|z(report) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/063-22-e/summary/summary.html|z(executive summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/063-22-e/index.html|z(complete dataset) |
|---|